UNSPSC 51282412: Azlocillin sodium

This classification denotes a penicillin antibiotic with the molecular formula C20H22N5O6S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DWV1EFW947, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-, monosodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as azlocillin sodium, which bears US NIH Compound Identifier 37623.

UNSPSC 51282412 Azlocillin sodium is a Commodity code that nominally refers to a specific antibiotic pharmaceutical. However, recent state and local contract opportunities posted under this code show substantial mismatch with the nominal scope — the actual procurements involve broader pharmaceutical and medical supply categories including naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical supplies, rather than azlocillin sodium specifically. State and local governments are using this code to solicit pharmaceuticals and medical consumables through a mix of issuing bodies: county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota MMCAP). The work being procured spans annual drug procurement through direct distribution, exploratory market intelligence on direct-to-manufacturer pharmacy programs, emergency medical supply for rescue operations, and multi-state generic pharmaceutical contracts distributed through authorized wholesalers.

Recent activity appears concentrated in Florida, Texas, and Minnesota. Representative recent opportunities include Seminole County's IFB 60459723LAS (due July 26, 2026, with an estimated annual volume of 1,900 units of naloxone and 800 safe drug deactivation systems for community health delivery), the City of Tampa's Bid 26-P-00145 for medical and first aid supplies totaling an estimated $700,000 with award to certified Small Local Business Enterprises at a 5 percent bid discount, the Texas Health and Human Services Commission's RFI HHS0017013 (due April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs, and MMCAP's RFP S1070000015802 (due March 26, 2026) establishing contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers with a two-year initial term and optional extensions. The code shows active state and local procurement activity, though the divergence between the nominal commodity name and actual solicited scope suggests vendors should verify code alignment in individual opportunities.